Andrew V. Schally
Section of Experimental Medicine
Department of Medicine
Tulane University School of Medicine
New Orleans
USA
Name/email consistency: low
- Targeting cytotoxic conjugates of somatostatin, luteinizing hormone-releasing hormone and bombesin to cancers expressing their receptors: a "smarter" chemotherapy. Nagy, A., Schally, A.V. Curr. Pharm. Des. (2005)
- Chemotherapy targeted to cancers through tumoral hormone receptors. Schally, A.V., Nagy, A. Trends Endocrinol. Metab. (2004)